| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |